Evidence map›Paper›PMID 36785687›Full record

ReviewThe Pan African medical journal2022

Prospects for tuberculosis elimination in Ethiopia: feasibility, challenges, and opportunities.

Tefera Belachew Agizew, Zewdu Gashu Dememew, Taye Leta, Nebiyu Hiruy, Emawayish Tesema, Eshetu Abdissa Abelti, Asfawesen Gebreyohannes, Yohannes Molla Alemayehu, Ahmed Bedru Omer, Pedro Guillermo Suarez and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in The Pan African medical journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Tefera Belachew AgizewUnited States Agency for International Development Eliminate Tuberculosis Project, Koninklijke Nederlandse Centrale Vereniging Tuberculosis Foundation, Addis Ababa, Ethiopia.
Zewdu Gashu DememewUnited States Agency for International Development Eliminate Tuberculosis Project, Management Sciences for Health, Addis Ababa, Ethiopia.
Taye LetaNational Tuberculosis and Leprosy Program, Federal Ministry of Health, Addis Ababa, Ethiopia.
Nebiyu HiruyUnited States Agency for International Development Eliminate Tuberculosis Project, Management Sciences for Health, Addis Ababa, Ethiopia.
Emawayish TesemaUnited States Agency for International Development Eliminate Tuberculosis Project, Koninklijke Nederlandse Centrale Vereniging Tuberculosis Foundation, Addis Ababa, Ethiopia.
Eshetu Abdissa AbeltiUnited States Agency for International Development Eliminate Tuberculosis Project, Koninklijke Nederlandse Centrale Vereniging Tuberculosis Foundation, Addis Ababa, Ethiopia.
Asfawesen GebreyohannesUnited States Agency for International Development Eliminate Tuberculosis Project, Koninklijke Nederlandse Centrale Vereniging Tuberculosis Foundation, Addis Ababa, Ethiopia.
Yohannes Molla AlemayehuUnited States Agency for International Development Eliminate Tuberculosis Project, Management Sciences for Health, Addis Ababa, Ethiopia.
Ahmed Bedru OmerUnited States Agency for International Development Eliminate Tuberculosis Project, Koninklijke Nederlandse Centrale Vereniging Tuberculosis Foundation, Addis Ababa, Ethiopia.
Pedro Guillermo SuarezManagement Sciences for Health, Arlington, Virginia, United States of America.
Yewulsew KassieUnited States Agency for International Development, Addis Ababa, Ethiopia.
Anteneh KassaUnited States Agency for International Development, Addis Ababa, Ethiopia.
Daniel GemechuUnited States Agency for International Development Eliminate Tuberculosis Project, Management Sciences for Health, Addis Ababa, Ethiopia.
Degu JereneKoninklijke Nederlandse Centrale Vereniging Tuberculosis Foundation, The Hague, The Netherlands.
United States Agency for International Development · USManagement Sciences for Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To end the global tuberculosis (TB) epidemic and eliminate TB, countries around the world committed to significantly expanding the scope of their efforts, including rapid uptake of new tools, interventions, and strategies, and envisioned a world free of TB. Between 2010 and 2020, Ethiopia experienced a 5% average annual decline in TB incidence. However, at that current rate, ending the TB epidemic (<10 TB cases/100,000 population) may not be possible soon. As a high TB and TB/HIV burden country, Ethiopia's TB epidemic is characterized by a high rate of transmission in the general population and hard-to-reach areas and progression of latent TB infection (LTBI) rather than cross-border migration. Studies suggest that a combination of interventions, such as intensive household screening with TB preventive therapy, has the potential to significantly decrease the incidence of TB. The feasibility of reducing the population-level TB incidence by a combination of interventions in Ethiopia is unknown. Based on the World Health Organization's TB elimination framework and the END TB strategic documents and previously published reviews in TB elimination we conducted a narrative review to summarize and estimated the effect of a combined intervention package (community-based TB screening for active case finding and TB and LTBI prevention and treatment among high-risk groups like household and close contacts). The projected annual decline of TB incidence was above 16%. With this level of impact and nationwide scale-up of the interventions, Ethiopia aligns well with ending the TB epidemic before 2035 and shifting toward TB elimination in the foreseeable future. In the Ethiopia setting, we recommend future studies generating evidence on the impact of the combination intervention package to reduce TB incidence in Ethiopia, which is aiming to shift from control to TB elimination.

Indexed as

Latent TuberculosisTuberculosis, MiliaryEthiopiaFeasibility StudiesGlobal HealthHumansIncidenceapproacheseliminationTuberculosis

Identifiers

PMID36785687
PMCPMC9922077
OpenAlexW4313048215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.